The Truth About Closed-Loop Marketing
Pharma sales forces were out, well, in force for a two-day leadership summit put on by the Center for Business Intelligence this week in Philadelphia. As a newbie on the pharma reporting scene, I...
View ArticleMarch Issue of Pharm Exec Online Now
The March issue of Pharmaceutical Executive Magazine is online and in the mail as we speak. The new issue features insights into the Pfizer/Wyeth merger, our annual media audit, a look at the new sales...
View ArticleGSK Signs $120M Deal to Market DMab Overseas
Image via Wikipedia In an effort to boost its sales force without hiring more sales reps, Amgen announced on Tuesday that it has signed a deal with GlaxoSmithKline to co-market its osteoporosis...
View ArticleLilly Sales Force Buyouts Revealed
Image via Wikipedia Lilly, on Tuesday, announced that it will offer 4,000 sales reps a buyout in hopes of reducing its sales force by 300 before year’s end. According to a Lilly spokesperson, this...
View ArticleShrinks Like Latuda Over the Competition, Survey Finds
Psychiatrists are more likely to recommend Sunovion Pharmaceuticals’ Latuda to colleagues than Merck’s Saphris or Novartis’ Fenapt, according to a DTW Marketing Research survey. All three drugs are...
View ArticleGSK Reps Trade Sales Targets for Sales Competencies
Last summer, GlaxoSmithKline announced plans to upend the pay structure for its US-based sales reps by removing incentives based on hard sales figures, or how many pills are sold. Instead of rewarding...
View ArticleSales Rep vs. eDetail: Consider the Practice Area
Forget illegal immigrants, it is machines that are stealing American jobs. For some medical practice areas, however, digital details haven’t sufficiently stepped in where their human sales rep...
View ArticleUsing Social Networks to Increase Sales
Social networks existed long before Mark Zuckerberg came along. What hasn’t existed until recently are the tools, metrics and case studies necessary to understand how physicians influence each other...
View ArticleBelviq's Battle of the Bulge
Arena Pharmaceuticals’ and marketing partner Eisai’s Belviq – the first FDA-approved drug to treat obesity in over a decade – is making progress with payers and beefing up sales forces to target...
View Article
More Pages to Explore .....